These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 16773520)

  • 41. Drug evaluation: TA-2711E in the treatment of active distal ulcerative colitis.
    Monteleone G; Caprioli F
    Curr Opin Investig Drugs; 2007 May; 8(5):423-8. PubMed ID: 17520872
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modulation of the Th1/Th2 balance by infliximab improves hyperthyroidism associated with a flare-up of ulcerative colitis.
    Matsumura K; Nakase H; Yamamoto S; Yoshino T; Takeda Y; Kasahara K; Ueno S; Uza N; Chiba T
    Inflamm Bowel Dis; 2009 Jul; 15(7):967-8. PubMed ID: 18942759
    [No Abstract]   [Full Text] [Related]  

  • 43. [Surgery, inflammatory bowel disease and biological treatment].
    Øresland T; Moum B
    Tidsskr Nor Laegeforen; 2009 Nov; 129(22):2389-90. PubMed ID: 19935950
    [No Abstract]   [Full Text] [Related]  

  • 44. Infliximab-related vasculitis in patients affected by ulcerative colitis.
    Pastore S; Londero M; Gortani G; Abate MV; Marchetti F; Di Leo G; Ventura A
    J Pediatr Gastroenterol Nutr; 2010 Aug; 51(2):226-8. PubMed ID: 20562717
    [No Abstract]   [Full Text] [Related]  

  • 45. Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children.
    Hyams J; Crandall W; Kugathasan S; Griffiths A; Olson A; Johanns J; Liu G; Travers S; Heuschkel R; Markowitz J; Cohen S; Winter H; Veereman-Wauters G; Ferry G; Baldassano R;
    Gastroenterology; 2007 Mar; 132(3):863-73; quiz 1165-6. PubMed ID: 17324398
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Short- and long-term response to and weaning from infliximab therapy in pediatric ulcerative colitis.
    Fanjiang G; Russell GH; Katz AJ
    J Pediatr Gastroenterol Nutr; 2007 Mar; 44(3):312-7. PubMed ID: 17325550
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and safety of infliximab in steroid-dependent ulcerative colitis patients.
    Gavalas E; Kountouras J; Stergiopoulos C; Zavos C; Gisakis D; Nikolaidis N; Giouleme O; Chatzopoulos D; Kapetanakis N
    Hepatogastroenterology; 2007 Jun; 54(76):1074-9. PubMed ID: 17629042
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Topically administered infliximab can work in ulcerative proctitis despite the ineffectiveness of intravenous induction therapy.
    Molnár T; Farkas K; Nagy F; Németh I; Wittmann T
    Am J Gastroenterol; 2009 Jul; 104(7):1857-8. PubMed ID: 19436284
    [No Abstract]   [Full Text] [Related]  

  • 49. [Current medical treatment of inflammatory bowel disease].
    Bosques-Padilla F
    Rev Gastroenterol Mex; 2007 Nov; 72 Suppl 2():92-101. PubMed ID: 18277494
    [No Abstract]   [Full Text] [Related]  

  • 50. [Azathioprine and 6-mercaptopurine for maintenance treatment in ulcerative colitis. A survey of a Cochrane review].
    Bjerrum JT; Nielsen OH
    Ugeskr Laeger; 2007 Dec; 169(50):4341-4. PubMed ID: 18211790
    [No Abstract]   [Full Text] [Related]  

  • 51. Re: "Posterior reversible encephalopathy syndrome following infliximab infusion".
    Zamvar V; Puntis JW
    J Pediatr Gastroenterol Nutr; 2010 Mar; 50(3):353. PubMed ID: 20190611
    [No Abstract]   [Full Text] [Related]  

  • 52. Development of communicating hydrocephalus after infliximab infusion.
    Maclennan A; Long MD; Herfarth HH
    Inflamm Bowel Dis; 2011 Feb; 17(2):E2-3. PubMed ID: 20848479
    [No Abstract]   [Full Text] [Related]  

  • 53. Antibiotics for acute laryngitis in adults.
    Ebell MH
    Am Fam Physician; 2005 Jul; 72(1):76-7. PubMed ID: 16035684
    [No Abstract]   [Full Text] [Related]  

  • 54. [Probiotics--from empirical medicine to therapeutic standard].
    Holst H; Breves G
    Z Gastroenterol; 2005 Jun; 43(6):601-6. PubMed ID: 15986291
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ECT treatment for autism: a viable alternative for a subgroup of patients?
    Datta SS
    Med Hypotheses; 2005; 64(1):219. PubMed ID: 15533648
    [No Abstract]   [Full Text] [Related]  

  • 56. The practice gap.
    Malik P
    Can J Cardiol; 2005 Feb; 21(2):143. PubMed ID: 15729412
    [No Abstract]   [Full Text] [Related]  

  • 57. Evidence, limes, and cement.
    Mandell BF
    Cleve Clin J Med; 2010 Jan; 77(1):7. PubMed ID: 20048023
    [No Abstract]   [Full Text] [Related]  

  • 58. [Effectiveness of intraportal infusion therapy of severe nonspecific ulcerative colitis].
    Novikova RI; Zavgorodniĭ LG; Pedenko VP
    Klin Khir (1962); 1977 Aug; (8):82-4. PubMed ID: 904163
    [No Abstract]   [Full Text] [Related]  

  • 59. New salicylates as maintenance treatment in ulcerative colitis.
    Järnerot G
    Gut; 1994 Sep; 35(9):1155-8. PubMed ID: 7959217
    [No Abstract]   [Full Text] [Related]  

  • 60. Clinical trials in ulcerative colitis: I. Personal observations.
    Korelitz BI; Margolin ML
    Am J Gastroenterol; 1988 Mar; 83(3):224-6. PubMed ID: 3344726
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.